AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 284: H256-H267, 2003. First published October 3, 2002; doi:10.1152/ajpheart.00220.2002
0363-6135/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/1/H256    most recent
00220.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (46)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, J.
Right arrow Articles by Salata, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J.
Right arrow Articles by Salata, J. J.
Vol. 284, Issue 1, H256-H267, January 2003

Functional and pharmacological properties of canine ERG potassium channels

Jixin Wang, Kimberly Della Penna, Hao Wang, Jerzy Karczewski, Thomas M. Connolly, Kenneth S. Koblan, Paul B. Bennett, and Joseph J. Salata

Department of Molecular Pharmacology, Merck Research Laboratories, West Point, Pennsylvania 19486

We established HEK-293 cell lines that stably express functional canine ether-à-go-go-related gene (cERG) K+ channels and examined their biophysical and pharmacological properties with whole cell patch clamp and 35S-labeled MK-499 ([35S]MK-499) binding displacement. Functionally, cERG current had the hallmarks of cardiac delayed rectifier K+ current (IKr). Channel opening was time- and voltage dependent with threshold near -40 mV. The half-maximum activation voltage was -7.8 ± 2.4 mV at 23°C, shifting to -31.9 ± 1.2 mV at 36°C. Channels activated with a time constant of 13 ± 1 ms at +20 mV, showed prominent inward rectification at depolarized potentials, were highly K+ selective (Na+-to-K+ permeability ratio = 0.007), and were potently inhibited by IKr blockers. Astemizole, terfenadine, cisapride, and MK-499 inhibited cERG and human ERG (hERG) currents with IC50 values of 1.3, 13, 19, and 15 nM and 1.2, 9, 14, and 21 nM, respectively, and competitively displaced [35S]MK-499 binding from cERG and hERG with IC50 values of 0.4, 12, 35, and 0.6 nM and 0.8, 5, 47, and 0.7 nM, respectively. cERG channels had biophysical properties appropriate for canine action potential repolarization and were pharmacologically sensitive to agents known to prolong QT. A novel MK-499 binding assay provides a new tool to detect agents affecting ERG channels.

ion channels; acquired long QT syndrome, potassium ion channel; ventricular arrhythmia; canine ether-à-go-go-related gene


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y. Zhu, J. Ye, and J. D. Huizinga
Clotrimazole-sensitive K+ currents regulate pacemaker activity in interstitial cells of Cajal
Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1715 - G1725.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
B. D. Guth
Preclinical Cardiovascular Risk Assessment in Modern Drug Development
Toxicol. Sci., May 1, 2007; 97(1): 4 - 20.
[Full Text] [PDF]

Home page
 J Biomol ScreenHome page
A. Finkel, A. Wittel, N. Yang, S. Handran, J. Hughes, and J. Costantin
Population Patch Clamp Improves Data Consistency and Success Rates in the Measurement of Ionic Currents
J Biomol Screen, August 1, 2006; 11(5): 488 - 496.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. Morita, D. P. Zipes, J. Lopshire, S. T. Morita, and J. Wu
T wave alternans in an in vitro canine tissue model of Brugada syndrome
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H421 - H428.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
H. Guthrie, F. S. Livingston, U. Gubler, and R. Garippa
A Place for High-Throughput Electrophysiology in Cardiac Safety: Screening hERG Cell Lines and Novel Compounds with the Ion Works HTTM System
J Biomol Screen, December 1, 2005; 10(8): 832 - 840.
[Abstract] [PDF]

Home page
 Cardiovasc ResHome page
J.M. Cordeiro, R. Brugada, Y.S. Wu, K. Hong, and R. Dumaine
Modulation of IKr inactivation by mutation N588K in KCNH2: A link to arrhythmogenesis in short QT syndrome
Cardiovasc Res, August 15, 2005; 67(3): 498 - 509.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
A. Dorn, F. Hermann, A. Ebneth, H. Bothmann, G. Trube, K. Christensen, and C. Apfel
Evaluation of a High-Throughput Fluorescence Assay Method for hERG Potassium Channel Inhibition
J Biomol Screen, June 1, 2005; 10(4): 339 - 347.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online